PATENT CLAIM ANALYSIS

Application Number: 15772455
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "547000"]

Abstract:
The present invention relates to pharmaceutical composition comprising dimethyl fumarate; an enzyme modulator or a permeation enhancer or both; and one or more pharmaceutically acceptable excipients. It further relates to a pulsatile release pharmaceutical composition comprising dimethyl fumarate and one or more pharmaceutically acceptable excipients. The compositions of the present invention are administered at a lower dose as compared to the recommended daily dose of Tecfidera®. Further, the compositions of the present invention are resistant to dose dumping in the presence of alcohol.

Claim (Index 3):
The pharmaceutical composition according to  claim 2 , wherein the esterase inhibitor is selected from the group consisting of EDTA and its salts; sodium lauryl sulfate, Tween\u00ae 20, polyoxyl 40 stearate, polyoxyl 35 castor oil, ascorbic acid, lecithin, polyoxyl 40 hydrogenated castor oil, Triton\u00ae X-100, poloxamer 188, Tween\u00ae 80, PEG 200, PEG 400, PEG 6000, PEG 4000, sodium alginate, mannitol, lactose, and mixtures thereof.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 91.0
- Lexical Diversity: 1.8
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15299535', '15386175', '15170421', '15248506', '15582913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8298831225869582
- 35 USC 102 Novelty (BERT): 0.5185967832243921
- Combined Prediction Score: 0.7987544886507015
- Mean Citation Score: 307.076842
- Max Citation Score: 314.52646
- Similarity Product: 212.28354246450783

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test